Cancer

Which medicines do we provide for cancer? This page lists approved medicines from around the world that can be prescribed to patients by doctors. Click on the product for prices – which we strive to ensure are the lowest available anywhere - and when you're ready to order just follow the process detailed. If you have an urgent question please contact us or use the chat tool.

For clinics, pharmacies and physicians: please contact us for larger batch requests or if you have a specific medicine you would like us to source.
pill
View Product

Alecensa

(alectinib)

by: Roche
for: Lung Cancer
from: 6366.65
• EMA approved (EU)
• FDA approved (USA)
• PMDA approved (JAP)
• TGA approved (AUS)

pill
View Product

Alunbrig

(brigatinib)

by: ARIAD Pharmaceuticals
for: Lung Cancer
from: 3143.19
• FDA approved (USA)
drip
View Product

Bavencio

(avelumab)

by: EMD Serono Inc.
for: Skin Cancer
from: 4683.00
• EMA approved (EU)
• FDA approved (USA)

drip
View Product

Beleodaq

(belinostat)

by: Spectrum Pharmaceuticals
for: Blood Cancer
from: 3010.50
• FDA approved (USA)
drip
View Product

Besponsa

(inotuzumab ozogamicin)

by: Pfizer
for: Acute Lymphoblastic Leukemia
from: 14272.00
• EMA approved (EU)
• FDA approved (USA)

drip
View Product

Blincyto

(blinatumomab)

by: Amgen
for: Blood Cancer
from: 3010.50
• EMA approved (EU)
• FDA approved (USA)
• TGA approved (AUS)

pill
View Product

Cabometyx

(cabozantinib)

by: Ipsen Pharma
for: Kidney Cancer
from: 8401.53
• EMA approved (EU)
• FDA approved (USA)

pill
View Product

Cometriq

(cabozantinib)

by: Exelixis Inc.
for: Thyroid Cancer
from: 5457.93
• EMA approved (EU)
• FDA approved (USA)

pill
View Product

Cotellic

(cobimetinib)

by: Genentech
for: Skin Cancer
from: 5519.25
• EMA approved (EU)
• FDA approved (USA)
• TGA approved (AUS)

drip
View Product

Darzalex

(daratumumab)

by: Janssen Biotech
for: Blood Cancer
from: 669.00
• EMA approved (EU)
• FDA approved (USA)
• TGA approved (AUS)

drip
View Product

Empliciti

(elotuzumab)

by: Bristol-Myers Squibb
for: Blood Cancer
from: 1633.48
• EMA approved (EU)
• FDA approved (USA)
• TGA approved (AUS)

pill
View Product

Ibrance

(palbociclib)

by: Pfizer
for: Breast Cancer
from: 4649.55
• EMA approved (EU)
• FDA approved (USA)
• TGA approved (AUS)

drip
View Product

Imfinzi

(durvalumab)

by: AstraZeneca
for: Bladder Cancer
from: 1449.50
• FDA approved (USA)
drip
View Product

Keytruda

(pembrolizumab)

by: Merck & co
for: Head and Neck Cancer / Lung Cancer / Urothelial Carcinoma / Skin Cancer / Lymphoma / MSI-H or dMMR solid tumours / Gastric Cancer
from: 1626.50
• EMA approved (EU)
• FDA approved (USA)
• TGA approved (AUS)

pill
View Product

Kisqali

(ribociclib)

by: Novartis
for: Breast Cancer
from: 4738.75
• EMA approved (EU)
• FDA approved (USA)

drip
View Product

Lartruvo

(olaratumab)

by: Eli Lilly and Co.
for: Soft-tissue Sarcoma
from: 1878.78
• EMA approved (EU)
• FDA approved (USA)

pill
View Product

Lonsurf

(trifluridine / tipiracil)

by: Taiho Pharmaceuticals
for: Colorectal Cancer
from: 830.95
• EMA approved (EU)
• FDA approved (USA)
• PMDA approved (JAP)

pill
View Product

Lynparza

(olaparib)

by: AstraZeneca
for: Ovarian Cancer
from: 6244.00
• EMA approved (EU)
• FDA approved (USA)
• TGA approved (AUS)

pill
View Product

Ninlaro

(ixazomib)

by: Takeda Pharmaceuticals
for: Blood Cancer
from: 9561.13
• EMA approved (EU)
• FDA approved (USA)
• TGA approved (AUS)

pill
View Product

Odomzo

(sonidegib)

by: Eli Lilly and Co.
for: Skin Cancer
from: 12621.80
• EMA approved (EU)
• FDA approved (USA)
• TGA approved (AUS)

drip
View Product

Onivyde

(irinotecan)

by: Baxalta Innovations GmbHMerrimack Pharmaceuticals Inc.
for: Pancreatic Cancer
from: 1044.64
• EMA approved (EU)
• FDA approved (USA)
• TGA approved (AUS)

drip
View Product

Opdivo

(nivolumab)

by: Bristol-Myers Squibb
for: Colorectal Cancer / Head and Neck Cancer / Hodgkin Lymphoma / Kidney Cancer / Lung Cancer / Skin Cancer / Bladder Cancer / Liver Cancer
from: 585.38
• EMA approved (EU)
• FDA approved (USA)
• PMDA approved (JAP)
• TGA approved (AUS)

drip
View Product

Perjeta

(pertuzumab)

by: Genentech
for: Breast Cancer
from: 2781.93
• EMA approved (EU)
• FDA approved (USA)
• TGA approved (AUS)

drip
View Product

Portrazza

(necitumumab)

by: Eli Lilly and Co.
for: Lung Cancer
from: 6913.00
• EMA approved (EU)
• FDA approved (USA)

pill
View Product

Rubraca

(rucaparib)

by: Clovis Oncology Inc.
for: Ovarian Cancer
from: 10648.25
• FDA approved (USA)
pill
View Product

Rydapt

(midostaurin)

by: Novartis
for: Blood Cancer
from: 8507.45
• EMA approved (EU)
• FDA approved (USA)

pill
View Product

Tagrisso

(osimertinib)

by: AstraZeneca
for: Lung Cancer
from: 9644.75
• EMA approved (EU)
• FDA approved (USA)
• TGA approved (AUS)

drip
View Product

Tecentriq

(atezolizumab)

by: Genentech
for: Lung Cancer / Bladder Cancer
from: 6455.85
• EMA approved (EU)
• FDA approved (USA)
• TGA approved (AUS)

pill
View Product

Venclexta / Venclyxto

(venetoclax)

by: AbbVie
for: Blood Cancer
from: 1031.38
• EMA approved (EU)
• FDA approved (USA)
• TGA approved (AUS)

pill
View Product

Venclexta / Venclyxto

(venetoclax)

by: AbbVie
for: Blood Cancer
from: 3958.25
• EMA approved (EU)
• FDA approved (USA)
• TGA approved (AUS)

pill
View Product

Zejula

(niraparib)

by: Tesaro
for: Ovarian, Fallopian Tubes and Peritoneal Cancer
from: 19847.00
• FDA approved (USA)
pill
View Product

Zykadia

(ceritinib)

by: Novartis
for: Lung Cancer
from: 5184.75
• EMA approved (EU)
• FDA approved (USA)
• TGA approved (AUS)

unknown
Enquire now

We may still be able to get it for you, provided that:

• it hasn't been approved and/or isn't available in your country
• you and your treating doctor have evaluated that the medicine is suitable for you, and your doctor writes a prescription for it.

Registered with the Dutch Ministry of Health as an independent intermediary, Registration number 6730 BEM
Registered as a USA Delaware LLC.



Share our website

Follow us


DISCLAIMER: The Services of TheSocialMedwork do not replace a physician-patient relationship and are not intended as medical advice. TheSocialMedwork provides patients and physicians with existing treatment options abroad and creates access to these options after the patient and physician have made a professional decision. Privacy Policy / Terms and Conditions
Our service uses cookies.